Viewing Study NCT03097003


Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2025-12-25 @ 4:48 PM
Study NCT ID: NCT03097003
Status: COMPLETED
Last Update Posted: 2020-04-27
First Post: 2017-03-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module